Browsing: weight

Backed by a £5million marketing investment from new owner Supreme, SlimFast has been remodeled into a ‘trusted everyday nutrition solution’ to support the growing number of shoppers who are looking to support protein intake, digestive health, hydration, recovery and healthy aging, alongside weight management

Eli Lilly’s Foundayo is the second oral weight-loss pill to be approved in Europe, after U.K. approval. On Monday, the U.K.’s Medicines and Healthcare products regulatory agency announced approval of orforglipron, to be marketed as Foundayo, for helping patients lose weight and manage type 2 diabetes. But there’s a catch for British patients: the drug…

About our expert: Brian I. Nwannunu, MD, MS, is an orthopedic surgeon with Texas Joint Institute. The medical information in this article is based on an interview with Dr. Nwannunu

Leslie Jones turned heads on the red carpet at Copenhagen Fashion Week, where she posed in a waist-cinching dress that showed off her impressive weight-loss progress

Diabetes drug records reveal a modest but measurable rise in hair shedding among GLP-1 users – and it’s usually reversible

Eli Lilly (NYSE:LLY) has secured U.K. approval for its once-daily weight-loss pill Foundayo, giving the drugmaker its first regulatory win for the treatment outside the U.S. and escalating its obesity battle with Novo Nordisk. The approval expands Lilly’s opportunity beyond injectable drugs such as Zepbound while giving patients a potentially simpler oral option in one…

Gut microbiomes may be an overlooked puzzle piece in the ‘thrifty gene hypothesis,’ ASU researcher says

THE UK has become the first country in Europe to approve a daily weight loss pill made by the same company as Mounjaro. 

GLP-1 weight loss tablet approval: why it matters for brokers | Insurance Business

MedPal AI plc (AIM: MPAL)has highlighted the UK approval of Eli Lilly’s once-daily oral GLP-1 treatment, Foundayo, which has been authorised for weight loss and weight maintenance in eligible adults